🇺🇸 FDA
Patent

US 9156786

Process to prepare treprostinil, the active ingredient in remodulin®

granted A61KA61K31/192A61P

Quick answer

US patent 9156786 (Process to prepare treprostinil, the active ingredient in remodulin®) held by United Therapeutics Corporation expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/192, A61P, A61P1/00, A61P1/14